medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2004, Número 6

Siguiente >>

Salud Mental 2004; 27 (6)


Genetic mapping studies of schizophrenia and bipolar disorder

Alarcón RD

Idioma: Ingles.
Referencias bibliográficas: 60
Paginas: 1-7
Archivo PDF: 44.46 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. BERGER GE, WOOD S, McGORRY PD: Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bull, 37:79-101, 2003.

  2. BERRETTINI W: Bipolar disorder and schizophrenia: convergent molecular data. Neuromolecular Med, 5:109-17, 2004.

  3. BROWN AS, SUSSER ES: In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev, 8:51-7, 2002.

  4. CHEN YS, AKULA N, DETERA-WADLEIGH SD, SCHULZE TG, THOMAS J, POTASH JB et al.: Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry, 9:87-92; image 5, 2004.

  5. CHUMAKOV I, BLUMENFELD M, GUERASSIMENKO O, CAVAREC L, PALICIO M, ABDERRAHIM H, BOUGUELERET L et al.: Genetic and physiological data implicating the new human gene G72 and the gene for Damino acid oxidase in schizophrenia. Proc Natl Acad Sci USA, 99:13675-80, 2002.

  6. DARWIN C: The Expression of the Emotions in Man and Animals. John Murray, England, 1972.

  7. DeLISI LE, MESEN A, RODRIGUEZ C, BERTHEAU A, LAPRADE B, LLACH M et al.: Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet, 114:497-508, 2002.

  8. DETERA-WADLEIGH SD, GOLDIN LR, SHERRINGTON R, ENCIO I, DE MIGUEL C et al.: Exclusion of linkage to 5q11-13 in families with schizophrenia and other psychiatric disorders. Nature, 340:391-3,1989.

  9. DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS: American Psychiatric Association, Washington DC, 1994.ANGST J: Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res , 57:5-13, 2002.

  10. EGELAND JA, GERHARD DS, PAULS DL, SUSSEX JN, KIDD KK et al.: Bipolar affective disorders linked to DNA markers on chromosome 11. Nature, 325:783-7, 1987.

  11. ENDICOTT J: Good diagnoses require good diagnosticians: collecting and integrating the data. Am J Med Genet, 105:48- 9, 2001.

  12. ESCAMILLA M, FREIMER N, REUS V: The genetics of bipolar disorder and schizophrenia. In: The Molecular and Genetic Basis of Neurological Disease. Butterworth-Heinemann, Boston, 1997.

  13. ESCAMILLA M, ONTIVEROS A, NICOLINI H, RAVENTOS H, MENDOZA R, DELGADO A et al.: Clinical characteristics of subjects from a multi-site genetics study of schizophrenia (sc) in Latin American families. Am J Med Genet, 114:846-847, 2002.

  14. ESCAMILLA M, RAVENTOS H, ALMASY L, MONTERO P, BALDERAS T, RODRIGUEZ S, LEVINSON DF: Linkage Disequilibrium Analysis of Schizophrenia and Schizoaffective Disorder in the Costa Rican Population: Preliminary Findings on Chromosome 13. Am J Med Genet, 105:599, 2001a.

  15. ESCAMILLA MA: Diagnosis and treatment of mood disorders that co-occur with schizophrenia. Psychiatr Serv, 52:911-9, 2001a.

  16. ESCAMILLA MA: Population isolates: their special value for locating genes for bipolar disorder. Bipolar Disord, 3:299- 317, 2001b.

  17. ESCAMILLA MA, MCINNES LA, SERVICE SK, SPESNY M, REUS VI et al.: Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. Am J Med Genet, 105:207-13, 2001b.

  18. ESCAMILLA MA, McINNES LA, SPESNY M, REUS VI, SERVICE SK et al.: Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. American J Human Genetics, 64:1670-8, 1999.

  19. FEIGHNER JP, ROBINS E, GUZE SB, WOODRUFF RA, JR., WINOKUR G et al.: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry, 26:57-63, 1972.

  20. GARNER C, MCINNES LA, SERVICE SK, SPESNY M, FOURNIER E et al.: Linkage analysis of a complex pedigree with severe bipolar disorder, using a Markov chain Monte Carlo method. Am J Hum Genet 68:1061-4, 2001.

  21. GUSELLA JF, WEXLER NS, CONNEALLY PM, NAYLOR SL, ANDERSON MA et al.: A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 306:234-8, 1983.

  22. HATTORI E, LIU C, BADNER JA, BONNER TI, CHRISTIAN SL et al.: Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet, 72:1131-40, 2003.

  23. HOWES OD, MCDONALD C, CANNON M, ARSENEAULT L, BOYDELL J, MURRAY RM Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol, (7 Suppl), 1:S7-S13, 2004.

  24. JARSKOG LF, SELINGER ES, LIEBERMAN JA, GILMORE JH: Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry, 161:109-15, 2004.

  25. KELSOE JR, GINNS EI, EGELAND JA, GERHARD DS, GOLDSTEIN AM et al.: Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature, 342:238-43, 1989.

  26. KELSOE JR, SPENCE MA, LOETSCHER E, FOGUET M, SADOVNICK AD et al.: A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA, 98:585-90, 2001.

  27. KOPONEN H, RANTAKALLIO P, VEIJOLA J, JONES P, JOKELAINEN J, ISOHANNI M: Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:9-13, 2004.

  28. MATHEWS CA, REUS VI: Genetic linkage in bipolar disorder. CNS Spectr, 8:891-904, 2003.

  29. MATHEWS CA, REUS VI, BEJARANO J, ESCAMILLA MA, FOURNIER E et al.: Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet, 14:13-23, 2004.

  30. McDONALD C, GRECH A, TOULOPOULOU T, SCHULZE K, CHAPPLE B et al.: Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives. Am J Med Genet, 114:616-25, 2002.

  31. McGLASHAN TH, HOFFMAN RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry, 57:637-48, 2000.

  32. McINNES LA, ESCAMILLA MA, SERVICE SK, REUS VI, LEON P et al.:. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proceedings of the National Academy of Sciences of the United States of America,. 93:13060-5, 1996.

  33. McKUSICK VA: Medalian inheritance in man. In: A Catalog of Human Genes and Genetic Disorders. John Hopkins University Press, Baltimore, 1998.

  34. MILLER P, LAWRIE SM, HODGES A, CLAFFERTY R, COSWAY R, JOHNSTONE EC: Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol, 36:338-42, 2001.

  35. MOLDIN SO: NIMH Human Genetics Initiative: 2003 update. Am J Psychiatry, 160:621-2, 2003.

  36. NICOLINI H, CRUZ C, CAMARENA B, OROZCO B, KENNEDY JL et al.: DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry, 1:461-5, 1996.

  37. NURNBERGER JI Jr, BLEHAR MC, KAUFMANN CA, YORK-COOLER C, SIMPSON SG et al.: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry, 51:849-59, 1994.

  38. NURNBERGER JI Jr., FOROUD T: Genetics of bipolar affective disorder. Curr Psychiatry Rep, 2:147-57, 2000.

  39. O’DONOVAN MC, WILLIAMS NM, OWEN MJ: Recent advances in the genetics of schizophrenia. Hum Mol Genet, 12 Spec No 2:R125-33, 2003.

  40. OPHOFF RA, ESCAMILLA MA, SERVICE SK, SPESNY M, MESHI DB, POON W et al.: Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet, 71:565-74, 2002.

  41. OSPINA-DUQUE J, DUQUE C, CARVAJAL-CARMONA L, ORTIZ-BARRIENTOS D, SOTO I, PINEDA N, CUARTAS M et al.: An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia. Neurosci Lett, 292:199-202, 2000.

  42. PRABAKARAN S, SWATTON JE, RYAN MM, HUFFAKER SJ, HUANG JJ et al.: Mitochondrial dysfunction in Schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry, 2004.

  43. RAO AV, BALACHANDRAN B: Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci, 5:291-309, 2002.

  44. READ J, ROSS CA: Psychological trauma and psychosis: another reason why people diagnosed schizophrenic must be offered psychological therapies. J Am Acad Psychoanal Dyn Psychiatry, 31:247-68, 2003.

  45. SCHULZE K, MCDONALD C, FRANGOU S, SHAM P, GRECH A et al.: Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biol Psychiatry, 53:562-70, 2003.

  46. SCHWAB SG, KNAPP M, MONDABON S, HALLMAYER J, BORRMANN-HASSENBACH M et al.: Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet, 72:185-90, 2003.

  47. SHERRINGTON R, BRYNJOLFSSON J, PETURSSON H, POTTER M, DUDLESTON K et al.: Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature, 336:164-7, 1988.

  48. SHIFMAN S, BRONSTEIN M, STERNFELD M, PISANTE-SHALOM A, LEV-LEHMAN E et al.: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet, 71:1296-302, 2002.

  49. SHINK E, MORISSETTE J, VILLENEUVE A, BORDELEAU L, ROCHETTE D et al.: Support for the presence of bipolar disorder susceptibility loci on chromosome 5: heterogeneity in a homogeneous population in Quebec. Prog Neuropsychopharmacol Biol Psychiatry, 26:1273-7, 2002.

  50. SOLLUWAY F: Freud, Biologist of the Mind. Harvard University Press, Cambridge, 1992.

  51. STEFANSSON H, SARGINSON J, KONG A, YATES P, STEINTHORSDOTTIR V et al.: Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet, 72:83-7, 2003.

  52. STEFANSSON H, SIGURDSSON E, STEINTHORSDOTTIR V, BJORNSDOTTIR S, SIGMUNDSSON T et al.: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet, 71:877-92, 2002.

  53. STEVENS A: The Two Million Year Old Self. Texas A&M University Press, College Station, Texas, 1997.

  54. STEVENS A: Archetype Revisited: An Updated Natural History of the Self. Inner City Books, Toronto, 2003.

  55. STRAUB RE, JIANG Y, MACLEAN CJ, MA Y, WEBB BT et al.: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet, 71:337-48, 2002.

  56. TSUANG M, FARAONE S: The Genetics of Mood Disorders. Vol ix. Johns Hopkins Press, Baltimore, 1990.

  57. VERDOUX H, SUTTER AL: Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology. Am J Med Genet, 114:898-905, 2002.

  58. WEINBERGER DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry, 44:660-9, 1987.

  59. WOLF SS, HYDE TM, WEINBERGER DR: Neurobiology of schizophrenia. Curr Opin Neurol Neurosurg, 6:86-92, 1993.

  60. YATHAM LN: Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics. Bipolar Disord, (5 Suppl) 2:7-19, 2003.




2020     |     www.medigraphic.com